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Background
Prostate cancer is the third most common cancer
among men in the world. The human kallikrein-2 gene
(KLK2 gene) contains a mutant (T) for wild-type (C)
allele substitution, resulting in a Trp to Arg change on
the 250th amino acid at the 784th nucleotide of KLK2
cDNA. The reports on polymorphism in the KLK2 gene
in relation to prostate cancer are contradictory among
American and Korean population. Reports are not avail-
able regarding polymorphism in KLK2 gene in relation
to prostate cancer in Indian population. The relationship
between mutants (T) for wild-type (C) allele substitution
of the KLK2, circulating human kallikrein-2 (hK2) levels
and prostate cancer risk in Indian population has been
examined.
Materials and methods
The study was limited to 15 subjects that include seven
patients with prostate cancer and six controls who were
persons with no cancer. Peripheral blood samples were
collected from subject and control. DNA was extracted
from these samples using standard protocol. DNA was
dissolved in 1X TE buffer and used for PCR reactions
for the amplification of 322bp KLK2 gene. Polymerase
chain reaction- Restriction fragment length polymorph-
ism (PCR-RFLP) procedure was employed using MspI to
detect this polymorphism. The enzyme recognizes the
4bp sequence 5ʹCCGG3ʹ at codon 226 of KLK2 gene.
PCR-RFLP products ware separated in 2% agarose gel
and viewed under Gel-doc system.
Results
The median age of the eight subjects diagnosed for
prostate cancer were 60, out of which 6 are found to be
homozygous for CC allele of KLK2 gene, 1 was hetero-
zygous having CT allele and 1 was homozygous for TT
allele. From 7 subjects diagnosed negative for prostate
cancer 2 were having the CT genotype and 5 were
found to have the TT genotype.
Conclusions
The study indicates a possible correlation among the C/
T polymorphism of the KLK2 gene and circulating levels
of hK2 and, in combination, may be predictive for pros-
tate cancer. Though significant association has been
found with small subjects, uses of allele marker for pros-
tate cancer need further extensive study with large num-
ber of subject.
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